Skip to content
Voiant Clinical
  • Voiant Hub Login
  • DARC Portal Login
  • Solutions
  • Technology
  • Therapeutic Areas
    • Oncology
    • Ophthal­mology
    • Respiratory
    • Cardio­vascular
  • Partners
  • Resources
    • Downloads
    • Research Publications
  • About
    • Company Overview
    • Leadership
    • News
    • Careers
    • Become a Reader
  • Request a Demo

Downloads

Voiant White Paper Considering Ocular Safety: Key Insights into Conducting Ophthalmic Assessments for Clinical Trials AI clinical trial imaging CRO monitoring guidelines non-ophthalmic drug developers systemic therapies oncology neurology CNS cancer infectious diseases cardiovascular Authors Jason S Slakter Hanna Rodriguez Coleman Stephanie Attebery Laura Guzman

White Paper

Considering Ocular Safety: Key Insights into Conducting Ophthalmic Assessments for Clinical Trials

Find out more
  • Solutions
  • Technology
    • Voiant Hub Login
    • DARC Portal Login
  • Therapeutic Areas
    • Oncology
    • Ophthal­mology
    • Respiratory
    • Cardio­vascular
  • Partners
    • Become a Partner
  • Resources
    • Downloads
    • Research Publications
  • About
    • Company Overview
    • Leadership
    • News
    • Careers
    • Become a Reader
    • Contact Us
    • Follow Us
© 2026 Voiant. All rights reserved. Terms of Use | Privacy Notice | Site Map